Who Owns TGAN?
TRANSPHORM INC — Institutional Ownership & 13F Holdings
$0.00
+0.00 (+0.00%)
Market Cap
—
Shares Outstanding
—
Institutional Holders
51
Total Inst. Value
$562.3M
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2024
Top 10 Institutional Holders(Q1 2024)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | Bank of New York Mellon Corp | $389.2M | 79,273 |
| 2 | Kohlberg Kravis Roberts & Co. L.P. | $119.9M | 24,411,968 |
| 3 | AMERIPRISE FINANCIAL INC | $23.2M | 4,722,304 |
| 4 | ALPINE ASSOCIATES MANAGEMENT INC. | $12.1M | 2,466,977 |
| 5 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | $4.7M | 959,567 |
| 6 | Carmignac Gestion | $2.5M | 513,852 |
| 7 | Skandinaviska Enskilda Banken AB (publ) | $1.9M | 395,971 |
| 8 | UBS Group AG | $1.6M | 331,654 |
| 9 | MILLENNIUM MANAGEMENT LLC | $1.6M | 328,593 |
| 10 | GABELLI FUNDS LLC | $1.4M | 284,200 |
Frequently Asked Questions
How many institutional investors hold TGAN?
As of Q1 2024, 51 institutional investors report holding TGAN (TRANSPHORM INC) in their 13F filings.
Which hedge fund owns the most TGAN?
The largest institutional holder of TGAN is Bank of New York Mellon Corp with $389.2M in shares.
Are institutions buying or selling TGAN?
This quarter, 51 institutions opened new positions in TGAN and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.